Dumaghan, Lanielyn C.
HRN: 28-56-69 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CO-AMOXICLAV 625MG (TAB)
02/18/2026
02/24/2026
PO
625mg
TID
SP NSVD With Perineal Repair
Checking Initial Appropriateness